Nyxoah S.A. is a medical technology company focused on developing and commercializing innovative therapeutic solutions for the treatment of obstructive sleep apnea (OSA). Their primary product features a novel implantable neurostimulator designed to improve airway muscle function during sleep, thereby reducing the frequency of breathing disruptions caused by OSA. Nyxoah's approach offers a minimally invasive alternative to traditional continuous positive airway pressure (CPAP) therapy, aimed at enhancing patient comfort and compliance. The company is dedicated to advancing the understanding and treatment of sleep disorders, striving to improve the quality of life for patients worldwide. Read More
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the closing bell. This significant surge is primarily attributed to the overwhelmingly positive clinical outcomes data presented for its next-generation
Nyxoah CEO Olivier Taelman said that the company has also trained surgeons, obtained Value Analysis Committee approvals, and achieved successful coverage from major payors.
